Comparing Therapies for Postmenopausal Osteoporosis Prevention and Treatment (Q35112397)

6 August 2017

Comparing therapies for postmenopausal osteoporosis prevention and treatment (English)

1 reference

6 August 2017

Comparing Therapies for Postmenopausal Osteoporosis Prevention and Treatment (English)

1 reference

postmenopausal osteoporosis

26 December 2023

main subject

osteoporosis

0 references

1 reference

Samantha F. Eichner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12708951

26 December 2023

Kimberly B. Lloyd

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12708951

26 December 2023

Erin M. Timpe

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12708951

26 December 2023

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

6 August 2017

http://journals.sagepub.com/doi/pdf/10.1345/aph.1C246

1 reference

http://journals.sagepub.com/doi/full-xml/10.1345/aph.1C246

26 December 2023

1 reference

Annals of Pharmacotherapy

26 December 2023

published in

1 reference

6 August 2017

37

1 reference

6 August 2017

5

1 reference

6 August 2017

711-724

1 reference

Osteoporosis prevention, diagnosis, and therapy

6 August 2017

1 reference

Calcium and vitamin D in osteoporosis

21 January 2018

1 reference

The response to calcitriol therapy in postmenopausal osteoporotic women is a function of initial calcium absorptive status.

21 January 2018

1 reference

Dietary modification with dairy products for preventing vertebral bone loss in premenopausal women: a three-year prospective study.

21 January 2018

1 reference

Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patients

21 January 2018

1 reference

Correcting calcium nutritional deficiency prevents spine fractures in elderly women.

21 January 2018

1 reference

Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial

21 January 2018

1 reference

Calcitriol treatment is not effective in postmenopausal osteoporosis

21 January 2018

1 reference

Vitamin D3 and calcium to prevent hip fractures in elderly women

21 January 2018

1 reference

Prolonged estrogen therapy in postmenopausal women

21 January 2018

1 reference

Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study

21 January 2018

1 reference

Low-dosage micronized 17 beta-estradiol prevents bone loss in postmenopausal women

21 January 2018

1 reference

The effect of postmenopausal estrogen therapy on bone density in elderly women

21 January 2018

1 reference

The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial.

21 January 2018

1 reference

Bone mineral density response to estrogen replacement in frail elderly women: a randomized controlled trial

21 January 2018

1 reference

Effects of hormone replacement therapy on clinical fractures and height loss: The Heart and Estrogen/Progestin Replacement Study (HERS).

21 January 2018

1 reference

Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women

21 January 2018

1 reference

Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women

21 January 2018

1 reference

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

21 January 2018

1 reference

Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups.

21 January 2018

1 reference

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

21 January 2018

1 reference

Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.

21 January 2018

1 reference

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

21 January 2018

1 reference

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

21 January 2018

1 reference

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

21 January 2018

1 reference

Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group

21 January 2018

1 reference

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

21 January 2018

1 reference

Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study

21 January 2018

1 reference

Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture

21 January 2018

1 reference

Effect of salcatonin given intranasally on early postmenopausal bone loss

21 January 2018

1 reference

An effective regimen of intranasal salmon calcitonin in early postmenopausal bone loss

21 January 2018

1 reference

Total and regional bone mineral content and fracture rate in postmenopausal osteoporosis treated with salmon calcitonin: a prospective study

21 January 2018

1 reference

A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women

21 January 2018

1 reference

Alendronate Prevents Postmenopausal Bone Loss in Women without Osteoporosis: A Double-Blind, Randomized, Controlled Trial

21 January 2018

1 reference

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

21 January 2018

1 reference

The roles of calcium and vitamin D in the prevention of osteoporosis

21 January 2018

9

1 reference

The Journal of Rheumatology

26 December 2023

11

23

15

Gallagher JC

1996

1 reference

Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age

26 December 2023

13

1 reference

Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women

26 December 2023

17

1 reference

Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study

26 December 2023

20

1 reference

Long-term estrogen replacement therapy prevents bone loss and fractures

26 December 2023

24

1 reference

Postmenopausal estrogen replacement: a long-term cohort study

26 December 2023

26

1 reference

Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium

26 December 2023

27

1 reference

Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy

26 December 2023

28

1 reference

Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

26 December 2023

32

1 reference

Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group

26 December 2023

39

1 reference

Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial

26 December 2023

41

1 reference

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

26 December 2023

54

1 reference

A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss

26 December 2023

60

1 reference

Intranasal salmon calcitonin for the prevention and treatment of postmenopausal osteoporosis

26 December 2023

61

1 reference

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group

26 December 2023

62

1 reference

1-Year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin

26 December 2023

65

1 reference

Effect of nasal salmon calcitonin on bone remodeling and bone mass in postmenopausal osteoporosis

26 December 2023

67

1 reference

Analgesic effect of Salmon calcitonin in osteoporotic vertebral fractures: A double-blind placebo-controlled clinical study

26 December 2023

68

1 reference

26 December 2023

Identifiers

DOI

10.1345/APH.1C246

1 reference

6 August 2017

1 reference